"electroporation; irreversible; prostatectomy; sugammadex; neostigmin; reversal; akcelerometry; neuromuscular blockade"@en . "Anesteziologie & intenzivn\u00ED medic\u00EDna" . "Adamus, Milan" . . . "[249BA2D421E8]" . "7"^^ . "Herold, Ivan" . "CZ - \u010Cesk\u00E1 republika" . "15110" . "6"^^ . . "Anesteziologick\u00E9 aspekty ireverzibiln\u00ED elektroporace karcinomu prostaty: antagonizace nervosvalov\u00E9 blok\u00E1dy sugammadexem vs. neostigminem - retrospektivn\u00ED studie"@cs . . . . "RIV/61989592:15110/13:33144321!RIV14-MSM-15110___" . . . . "Pabi\u0161ta, Richard" . "Anesteziologick\u00E9 aspekty ireverzibiln\u00ED elektroporace karcinomu prostaty: antagonizace nervosvalov\u00E9 blok\u00E1dy sugammadexem vs. neostigminem - retrospektivn\u00ED studie" . "Objective:Assessment of factors influencing the reversal of neuromuscular blockade with sugammadex (S) and neostigmin (N) in IRE prostatectomy requiring deep neuromuscular block until the end of surgery. Type:Retrospective study, analysis of anaesthesia charts. Setting:Department of Urology, Department of Anaesthe- siology and Intensive Therapy. Materials and methods:During a 5-month period (November 2011-March 2012) IRE prostatectomy were performed in 35 men in balanced general anaesthesia with rocuronium. At the end of surgery, S 200 mg (BRIDION) or N (NEOSTIGMIN) were administered for the reversal of deep block (TOF-count 0, PTC ? 5) or moderate block (TOF-count ? 1) respectively. We analysed the relation of the reversal to the rocuronium admini- stration: the intubation dose, total dose (absolute, per kg of body weight, number of supplementing boluses), duration of anaesthesia and ASA using non-parametric Mann Whitney and Fischer exact tests. Results are presented as mean values.Results: Sugammadex 200 mg (2.21 mg/kg) was administered in 22 (63%) patients with deep block (BRIDION group), neostigmin (0.027 mg/kg) in 13 (37%) patients with moderate block (NEOSTIGMIN group). Comparing to NEOSTIGMIN, higher doses of rocuronium - absolute dose (82.5 vs 65 mg, p = 0.001) and dose/kg bw (0.85 vs 0.69 mg/kg, p = 0.018) were given, the number of rocuronium boluses was higher (p = 0.013) and the anaesthesia was longer (100 vs 90 min, p = 0.044) in the BRIDION group. A dose of S 200 mg was sufficient in 20 patients (91 %) for block reversal. In 2 patients with a lower sugammadex dose ({ 1.6 mg/kg), a supplement dose of 100 mg was required for complete block recovery after 3.5 min. Conclusion:In IRE prostatectomy, rocuronium-sugammadex combination appears to be a cost-effective strategy. A standard dose of 200 mg sugammadex at the end of surgery might be insufficient in obese patients (in doses { 1.6 mg/kg)."@en . "24" . . "Kolombo, Ivan" . "1"^^ . "Sittov\u00E1, Nad\u011B\u017Eda" . . "Anesteziologick\u00E9 aspekty ireverzibiln\u00ED elektroporace karcinomu prostaty: antagonizace nervosvalov\u00E9 blok\u00E1dy sugammadexem vs. neostigminem - retrospektivn\u00ED studie" . "1214-2158" . "Anaesthesia for irreversible electroporation (IRE) prostatectomy: Reversal of neuromuscular blockade with sugammadex vs neostigmin. Retrospective study Anaesthesia for irreversible electroporation (IRE) prostatectomy: Reversal of neuromuscular blockade with sugammadex vs neostigmin. Retrospective study Anaesthesia for irreversible electroporation (IRE) prostatectomy: Reversal of neuromuscular blockade with sugammadex vs neostigmin. Retrospective study"@en . . . . "\u010Curdov\u00E1, Marcela" . "4" . "C\u00EDl: Ur\u010Dit faktory ovliv\u0148uj\u00EDc\u00ED antagonizaci nervosvalov\u00E9 blok\u00E1dy sugammadexem (S) vs. neostigminem (N) u IRE prostatektomie vy\u017Eaduj\u00EDc\u00ED hlubokou svalovou relaxaci. Typ studie:Retrospektivn\u00ED studie formou rozboru anesteziologick\u00FDch z\u00E1znam\u016F. Pracovi\u0161t\u011B:Urologick\u00E9 odd\u011Blen\u00ED a Anesteziologicko-resuscita\u010Dn\u00ED odd\u011Blen\u00ED. Materi\u00E1l a metody:V obdob\u00ED XI/2011-III/2012 byly provedeny IRE prostatektomie u 35 mu\u017E\u016F v dopl\u0148ovan\u00E9 anestezii se svalovou relaxac\u00ED rokuroniem. Podle hloubky nervosvalov\u00E9 blok\u00E1dy na konci operace byl p\u0159i hlubok\u00E9m bloku (TOF-count 0, PTC ? 5) pod\u00E1n S 200 mg (BRIDION), p\u0159i m\u011Blk\u00E9m bloku (TOF-count ? 1) to byl N (NEOSTIGMIN). Analyzovali jsme dekurarizaci ve vztahu ke zp\u016Fsobu pod\u00E1n\u00ED rokuronia (intuba\u010Dn\u00ED d\u00E1vce, celkov\u00E9 d\u00E1vce, po\u010Dtu dopl\u0148uj\u00EDc\u00EDch d\u00E1vek, d\u00E9lce anestezie a ASA) pomoc\u00ED neparametrick\u00E9ho Mannova-Whitneyova testu a Fisherova p\u0159esn\u00E9ho testu. V\u00FDsledky jsou uvedeny jako medi\u00E1n. V\u00FDsledky:U 22 pacient\u016F (63 %) ve skupin\u011B BRIDION byl pod\u00E1n S v d\u00E1vce 200 mg (2,21 mg/kg), u 13 (37 %) byl m\u011Blk\u00FD blok antagonizov\u00E1n N (0,027 mg/kg). Ve skupin\u011B BRIDION byla pod\u00E1na vy\u0161\u0161\u00ED celkov\u00E1 d\u00E1vka rokuronia absolutn\u00ED (82,5 vs. 65 mg/kg p = 0,001) i p\u0159epo\u010Dten\u00E1 na t\u011Blesnou hmotnost (0,85 vs. 0,69 mg/kg p = 0,018), v\u011Bt\u0161\u00ED po\u010Det bolus\u016F (p = 0,013) a anestezie byly del\u0161\u00ED (100 vs. 90 min, p = 0,044). D\u00E1vka S 200 mg byla dostate\u010Dn\u00E1 u 20 pacient\u016F (91 %). U 2 pacient\u016F, jim\u017E byl S pod\u00E1n v ni\u017E\u0161\u00ED d\u00E1vce ({ 1,6 mg/kg), byla nutn\u00E1 dopl\u0148uj\u00EDc\u00ED d\u00E1vka 100 mg S. Z\u00E1v\u011Br:K antagonizaci hlubok\u00E9ho nervosvalov\u00E9ho bloku p\u0159i IRE prostatektomii je kombinace rokuronium-sugammadex n\u00E1kladov\u011B efektivn\u00ED. U ob\u00E9zn\u00EDch pacient\u016F m\u016F\u017Ee b\u00FDt standardn\u00ED d\u00E1vka 200 mg sugammadexu ({ 1,6 mg/kg) nedostate\u010Dn\u00E1."@cs . . . . . "C\u00EDl: Ur\u010Dit faktory ovliv\u0148uj\u00EDc\u00ED antagonizaci nervosvalov\u00E9 blok\u00E1dy sugammadexem (S) vs. neostigminem (N) u IRE prostatektomie vy\u017Eaduj\u00EDc\u00ED hlubokou svalovou relaxaci. Typ studie:Retrospektivn\u00ED studie formou rozboru anesteziologick\u00FDch z\u00E1znam\u016F. Pracovi\u0161t\u011B:Urologick\u00E9 odd\u011Blen\u00ED a Anesteziologicko-resuscita\u010Dn\u00ED odd\u011Blen\u00ED. Materi\u00E1l a metody:V obdob\u00ED XI/2011-III/2012 byly provedeny IRE prostatektomie u 35 mu\u017E\u016F v dopl\u0148ovan\u00E9 anestezii se svalovou relaxac\u00ED rokuroniem. Podle hloubky nervosvalov\u00E9 blok\u00E1dy na konci operace byl p\u0159i hlubok\u00E9m bloku (TOF-count 0, PTC ? 5) pod\u00E1n S 200 mg (BRIDION), p\u0159i m\u011Blk\u00E9m bloku (TOF-count ? 1) to byl N (NEOSTIGMIN). Analyzovali jsme dekurarizaci ve vztahu ke zp\u016Fsobu pod\u00E1n\u00ED rokuronia (intuba\u010Dn\u00ED d\u00E1vce, celkov\u00E9 d\u00E1vce, po\u010Dtu dopl\u0148uj\u00EDc\u00EDch d\u00E1vek, d\u00E9lce anestezie a ASA) pomoc\u00ED neparametrick\u00E9ho Mannova-Whitneyova testu a Fisherova p\u0159esn\u00E9ho testu. V\u00FDsledky jsou uvedeny jako medi\u00E1n. V\u00FDsledky:U 22 pacient\u016F (63 %) ve skupin\u011B BRIDION byl pod\u00E1n S v d\u00E1vce 200 mg (2,21 mg/kg), u 13 (37 %) byl m\u011Blk\u00FD blok antagonizov\u00E1n N (0,027 mg/kg). Ve skupin\u011B BRIDION byla pod\u00E1na vy\u0161\u0161\u00ED celkov\u00E1 d\u00E1vka rokuronia absolutn\u00ED (82,5 vs. 65 mg/kg p = 0,001) i p\u0159epo\u010Dten\u00E1 na t\u011Blesnou hmotnost (0,85 vs. 0,69 mg/kg p = 0,018), v\u011Bt\u0161\u00ED po\u010Det bolus\u016F (p = 0,013) a anestezie byly del\u0161\u00ED (100 vs. 90 min, p = 0,044). D\u00E1vka S 200 mg byla dostate\u010Dn\u00E1 u 20 pacient\u016F (91 %). U 2 pacient\u016F, jim\u017E byl S pod\u00E1n v ni\u017E\u0161\u00ED d\u00E1vce ({ 1,6 mg/kg), byla nutn\u00E1 dopl\u0148uj\u00EDc\u00ED d\u00E1vka 100 mg S. Z\u00E1v\u011Br:K antagonizaci hlubok\u00E9ho nervosvalov\u00E9ho bloku p\u0159i IRE prostatektomii je kombinace rokuronium-sugammadex n\u00E1kladov\u011B efektivn\u00ED. U ob\u00E9zn\u00EDch pacient\u016F m\u016F\u017Ee b\u00FDt standardn\u00ED d\u00E1vka 200 mg sugammadexu ({ 1,6 mg/kg) nedostate\u010Dn\u00E1." . "61244" . "I" . . "RIV/61989592:15110/13:33144321" . "Anesteziologick\u00E9 aspekty ireverzibiln\u00ED elektroporace karcinomu prostaty: antagonizace nervosvalov\u00E9 blok\u00E1dy sugammadexem vs. neostigminem - retrospektivn\u00ED studie"@cs . . "Anaesthesia for irreversible electroporation (IRE) prostatectomy: Reversal of neuromuscular blockade with sugammadex vs neostigmin. Retrospective study Anaesthesia for irreversible electroporation (IRE) prostatectomy: Reversal of neuromuscular blockade with sugammadex vs neostigmin. Retrospective study Anaesthesia for irreversible electroporation (IRE) prostatectomy: Reversal of neuromuscular blockade with sugammadex vs neostigmin. Retrospective study"@en .